Literature DB >> 15634734

Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord.

A Buss1, K Pech, D Merkler, B A Kakulas, D Martin, J Schoenen, J Noth, M E Schwab, G A Brook.   

Abstract

Axons undergo Wallerian degeneration (WD) distal to a point of injury. In the lesioned PNS, WD may be followed by successful axonal regeneration and functional recovery. However, in the lesioned mammalian CNS, there is no significant axonal regeneration. Myelin-associated proteins (MAPs) have been shown to play significant roles in preventing axonal regeneration in the CNS. Since relatively little is known about such events in human CNS pathologies, we performed an immunohistochemical investigation on the temporal changes of four MAPs during WD in post-mortem spinal cords of 22 patients who died 2 days to 30 years after either cerebral infarction or traumatic spinal cord injury. In contrast to experimental studies in rats, the loss of myelin sheaths is greatly delayed in humans and continues slowly over a number of years. However, in agreement with animal data, a sequential loss of myelin proteins was found which was dependent on their location within the myelin sheath. Myelin proteins situated on the peri-axonal membrane were the first to be lost, the time course correlating with the loss of axonal markers. Proteins located within compact myelin or on the outer myelin membrane were still detectable 3 years after injury in degenerating fibre tracts, long after the disappearance of the corresponding axons. The persistence of axon growth-inhibitory proteins such as NOGO-A in degenerating nerve fibre tracts may contribute to the maintenance of an environment that is hostile to axon regeneration, long after the initial injury. The present data highlight the importance of correlating the well documented, lesion-induced changes that take place in controlled laboratory investigations with those that take place in the clinical domain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634734     DOI: 10.1093/brain/awh355

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  33 in total

Review 1.  Myelin as an inflammatory mediator: Myelin interactions with complement, macrophages, and microglia in spinal cord injury.

Authors:  Timothy J Kopper; John C Gensel
Journal:  J Neurosci Res       Date:  2017-07-11       Impact factor: 4.164

Review 2.  Myelin status and oligodendrocyte lineage cells over time after spinal cord injury: What do we know and what still needs to be unwrapped?

Authors:  Nicole Pukos; Matthew T Goodus; Fatma R Sahinkaya; Dana M McTigue
Journal:  Glia       Date:  2019-08-24       Impact factor: 7.452

3.  MRI findings in a case of spinal cord Wallerian degeneration following trauma.

Authors:  Puneet Mittal; Ranjana Gupta; Amit Mittal; Kapish Mittal
Journal:  Neurosciences (Riyadh)       Date:  2016-10       Impact factor: 0.906

Review 4.  Glial Cells Shape Pathology and Repair After Spinal Cord Injury.

Authors:  Andrew D Gaudet; Laura K Fonken
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

5.  Subject-specific regional measures of water diffusion are associated with impairment in chronic spinal cord injury.

Authors:  Ann S Choe; Cristina L Sadowsky; Seth A Smith; Peter C M van Zijl; James J Pekar; Visar Belegu
Journal:  Neuroradiology       Date:  2017-06-08       Impact factor: 2.804

6.  Phagocytic removal of neuronal debris by olfactory ensheathing cells enhances neuronal survival and neurite outgrowth via p38MAPK activity.

Authors:  Bao-Rong He; Song-Tao Xie; Ming-Mei Wu; Ding-Jun Hao; Hao Yang
Journal:  Mol Neurobiol       Date:  2013-11-22       Impact factor: 5.590

7.  Acute infarcts cause focal thinning in remote cortex via degeneration of connecting fiber tracts.

Authors:  Marco Duering; Ruthger Righart; Frank Arne Wollenweber; Vera Zietemann; Benno Gesierich; Martin Dichgans
Journal:  Neurology       Date:  2015-03-25       Impact factor: 9.910

Review 8.  Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.

Authors:  Roman J Giger; Karthik Venkatesh; Onanong Chivatakarn; Stephen J Raiker; Laurie Robak; Thomas Hofer; Hakjoo Lee; Christoph Rader
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

Review 9.  Therapeutics targeting Nogo-A hold promise for stroke restoration.

Authors:  Prateek Kumar; Lawrence D F Moon
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-03       Impact factor: 4.388

10.  Loss of myelin-associated glycoprotein in kearns-sayre syndrome.

Authors:  Nichola Z Lax; Graham R Campbell; Amy K Reeve; Nobuhiko Ohno; Jessica Zambonin; Emma L Blakely; Robert W Taylor; Eduardo Bonilla; Kurenai Tanji; Salvatore DiMauro; Evelyn Jaros; Hans Lassmann; Doug M Turnbull; Don J Mahad
Journal:  Arch Neurol       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.